Compile Data Set for Download or QSAR
Report error Found 89 Enz. Inhib. hit(s) with all data for entry = 1312
TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316366(US9617239, BRITE-354972)
Affinity DataIC50: 1nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316459(US9617239, BRITE-492802)
Affinity DataIC50: 30nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316467(US9617239, BRITE-492808)
Affinity DataIC50: 30nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316461(US9617239, BRITE-492805)
Affinity DataIC50: 40nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316468(US9617239, BRITE-492809)
Affinity DataIC50: 40nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316457(US9617239, BRITE-492800)
Affinity DataIC50: 70nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316456(US9617239, BRITE-492799)
Affinity DataIC50: 70nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316454(US9617239, BRITE-492797)
Affinity DataIC50: 90nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316367(US9617239, BRITE-355123)
Affinity DataIC50: 90nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316368(US9617239, BRITE-355252)
Affinity DataIC50: 90nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316460(US9617239, BRITE-492803)
Affinity DataIC50: 100nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316369(US9617239, BRITE-354975)
Affinity DataIC50: 120nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316453(US9617239, BRITE-492796)
Affinity DataIC50: 120nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316466(US9617239, BRITE-492807)
Affinity DataIC50: 130nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316370(US9617239, BRITE-354989)
Affinity DataIC50: 150nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316371(US9617239, BRITE-354909)
Affinity DataIC50: 170nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316372(US9617239, BRITE-354725)
Affinity DataIC50: 190nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316373(US9617239, BRITE-354969)
Affinity DataIC50: 200nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316375(US9617239, BRITE-355006)
Affinity DataIC50: 210nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316374(US9617239, BRITE-355417)
Affinity DataIC50: 210nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316376(US9617239, BRITE-355017)
Affinity DataIC50: 220nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316377(US9617239, BRITE-354979)
Affinity DataIC50: 230nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316378(US9617239, BRITE-355004)
Affinity DataIC50: 240nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316380(US9617239, BRITE-354966)
Affinity DataIC50: 270nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316379(US9617239, BRITE-354667)
Affinity DataIC50: 270nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316381(US9617239, BRITE-355262)
Affinity DataIC50: 280nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316383(US9617239, BRITE-354873)
Affinity DataIC50: 290nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316382(US9617239, BRITE-354965)
Affinity DataIC50: 290nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316462(US9617239, BRITE-492806)
Affinity DataIC50: 300nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316384(US9617239, BRITE-354615)
Affinity DataIC50: 310nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316385(US9617239, BRITE-355016)
Affinity DataIC50: 320nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316386(US9617239, BRITE-354517)
Affinity DataIC50: 320nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316455(US9617239, BRITE-492798)
Affinity DataIC50: 330nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316387(US9617239, BRITE-354958)
Affinity DataIC50: 330nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316388(US9617239, BRITE-355360)
Affinity DataIC50: 340nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316389(US9617239, BRITE-355227)
Affinity DataIC50: 350nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316394(US9617239, BRITE-354948)
Affinity DataIC50: 390nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316395(US9617239, BRITE-355336)
Affinity DataIC50: 410nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316396(US9617239, BRITE-355423)
Affinity DataIC50: 430nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316397(US9617239, BRITE-355468)
Affinity DataIC50: 500nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316399(US9617239, BRITE-355003)
Affinity DataIC50: 510nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316398(US9617239, BRITE-355202)
Affinity DataIC50: 510nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316400(US9617239, BRITE-354946)
Affinity DataIC50: 560nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316401(US9617239, BRITE-354983)
Affinity DataIC50: 570nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316402(US9617239, BRITE-355014)
Affinity DataIC50: 600nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316403(US9617239, BRITE-355015)
Affinity DataIC50: 630nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316404(US9617239, BRITE-354627)
Affinity DataIC50: 710nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316406(US9617239, BRITE-354764)
Affinity DataIC50: 730nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316407(US9617239, BRITE-354993)
Affinity DataIC50: 730nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

TargetBeta-glucuronidase(Human)
North Carolina Central University

US Patent
LigandPNGBDBM316408(US9617239, BRITE-354956)
Affinity DataIC50: 750nMAssay Description:The β-glucuronidase assay was performed by the addition of 0.5 μl of compound (or DMSO) to the well of a black 384-well plate followed by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2019
Entry Details
US Patent

Displayed 1 to 50 (of 89 total ) | Next | Last >>
Jump to: